Free Trial

Avantor (AVTR) Stock Price, News & Analysis

Avantor logo
$20.78 +0.42 (+2.06%)
(As of 11/22/2024 ET)

About Avantor Stock (NYSE:AVTR)

Key Stats

Today's Range
$20.25
$20.85
50-Day Range
$19.72
$27.70
52-Week Range
$19.59
$28.00
Volume
7.51 million shs
Average Volume
7.18 million shs
Market Capitalization
$14.14 billion
P/E Ratio
45.17
Dividend Yield
N/A
Price Target
$27.57
Consensus Rating
Moderate Buy

Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
100th Percentile Overall Score

AVTR MarketRank™: 

Avantor scored higher than 100% of companies evaluated by MarketBeat, and ranked 15th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avantor has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 12 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avantor has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Avantor's stock forecast and price target.
  • Earnings Growth

    Earnings for Avantor are expected to grow by 15.31% in the coming year, from $0.98 to $1.13 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avantor is 45.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.97.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avantor is 45.17, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.45.

  • Price to Earnings Growth Ratio

    Avantor has a PEG Ratio of 2.47. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Avantor has a P/B Ratio of 2.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Avantor's valuation and earnings.
  • Percentage of Shares Shorted

    3.39% of the outstanding shares of Avantor have been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 30.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Avantor does not currently pay a dividend.

  • Dividend Growth

    Avantor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.39% of the outstanding shares of Avantor have been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 30.19%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Avantor has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 24 news articles for Avantor this week, compared to 9 articles on an average week.
  • Search Interest

    4 people have searched for AVTR on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avantor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $88,336.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of Avantor is held by insiders.

  • Percentage Held by Institutions

    95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avantor's insider trading history.
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock News Headlines

Avantor to Distribute Quantum-Si Technology
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
FY2024 EPS Estimates for Avantor Decreased by Zacks Research
See More Headlines

AVTR Stock Analysis - Frequently Asked Questions

Avantor's stock was trading at $22.83 on January 1st, 2024. Since then, AVTR shares have decreased by 9.0% and is now trading at $20.78.
View the best growth stocks for 2024 here
.

Avantor, Inc. (NYSE:AVTR) issued its earnings results on Friday, April, 26th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.02. The firm's revenue for the quarter was down 5.6% compared to the same quarter last year.

Avantor (AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Top institutional investors of Avantor include State Street Corp (3.29%), Janus Henderson Group PLC (2.60%), Geode Capital Management LLC (1.64%) and UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.19%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Christophe Couturier, Thomas A Szlosek, Steven W Eck and Rajiv Gupta.
View institutional ownership trends
.

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Humana (HUM), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
4/26/2024
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/12/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.57
High Stock Price Target
$34.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+32.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
15 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
5.71%

Debt

Sales & Book Value

Annual Sales
$6.82 billion
Cash Flow
$1.77 per share
Book Value
$8.16 per share

Miscellaneous

Free Float
670,405,000
Market Cap
$14.15 billion
Optionable
Optionable
Beta
1.35
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:AVTR) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners